Information for Injection site rotation
Page information·measured at build time
Technical and provenance information about Injection site rotation. All figures on this page are measured from the emitted page rather than declared.
Basic information
| Display title | Injection site rotation |
|---|---|
| Default sort key | Injection site rotation |
| Namespace | Article (main) |
| Page kind | Concept |
| Page length (source, bytes) | 4,872 |
| Rendered word count | 576 |
| Internal wiki links on the page | 10 |
| Defined citations | 4 |
| Top-level sections | 3 |
| Subsections | 0 |
| Tables | 1 |
| Figures | 0 |
| Infobox | Yes — concept |
| Maintenance banners | None |
| Indexing by robots | Allowed |
Edit history
| Page creator | FlowTrialFraser |
|---|---|
| Date of page creation | 8 September 2024 |
| Latest editor | RotationRosalind |
| Date of latest edit | 20 July 2026 |
| Total number of edits | 26 |
| Total number of distinct authors | 22 |
| Minor edits | 15 |
| Automated (bot) edits | 4 |
| Recent number of edits (last 90 days) | 3 |
| Talk page posts | 4 |
Principal authors
| Editor | Edits | Share | Declared focus |
|---|---|---|---|
| CategoryBot | 3 | 11.5% | categorisation and navigation |
| eGFR_Esme | 2 | 7.7% | laboratory medicine and biomarkers |
| RotationRosalind | 2 | 7.7% | dosing, titration and injection practice |
| FlowTrialFraser | 1 | 3.8% | clinical trials and evidence appraisal |
| INN_Ingrid | 1 | 3.8% | GLP-1 receptor agonists and related compounds |
| StabilityStig | 1 | 3.8% | dosing, titration and injection practice |
| TitrationTheo | 1 | 3.8% | dosing, titration and injection practice |
| GMP_Gita | 1 | 3.8% | compounding law and drug regulation |
| BUD_Bertram | 1 | 3.8% | dosing, titration and injection practice |
| ResinRhoswen | 1 | 3.8% | peptide synthesis and supply chain |
| NauseaNoor | 1 | 3.8% | adverse effects and clinical safety |
| Hedgerow_Hal | 1 | 3.8% | copy-editing and the manual of style |
Category membership
- Category:Injection technique — 7 member pages
- Category:Clinical practice — 23 member pages
- Category:Adverse effects — 8 member pages